MedTrace Logo

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness

NCT05617794 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-05

No results posted yet for this study

Summary

The objective of the study is to measure the effect of Diffusion Optics Technology (DOT) spectacle lenses on the choroidal thickness and choroidal vascularity index compared to control lenses.

Conditions

  • Myopia
  • Myopia Progression
  • Juvenile Myopia

Interventions

DEVICE

Diffusion Optics Technology (DOT) Pattern Spectacle Lens

DOT Pattern Spectacle Lens

DEVICE

Control Spectacle Lens

Control Spectacles

Sponsors & Collaborators

  • University of Waterloo

    collaborator OTHER

  • SightGlass Vision, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
8 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-18
Primary Completion
2023-04-30
Completion
2026-12-31
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05617794 on ClinicalTrials.gov